Company Profile
electroCore Stock Price, News & Analysis
- Ticker:
- ECOR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
6.09 USD (+0.66%)
Close
Last updated: July 28, 2026
78.4M USD
Market cap
Why the stock is moving
As of Jul 28, 2026, ECOR closed up 0.66% at $6.09. No new same-company headline was identified in the current news window.
Company overview
Business overview
electroCore is a bioelectronic medicine company focused on non-invasive vagus nerve stimulation and related neuromodulation applications. Its business centers on device-based therapy rather than traditional pharmaceuticals.
Geographic Base and Sector Classification
electroCore is headquartered in the United States and listed on NASDAQ, with a profile in neuromodulation and medical devices. It sits outside biotech and closer to digital or device-enabled therapeutics.
Business Model Characteristics
The company depends on device adoption, reimbursement progress, consumer or clinical channel expansion, and the ability to translate neuromodulation into repeatable usage. Investors watch sales execution and regulatory access more than clinical-trial readouts.
Position Within the Biotechnology Landscape
electroCore occupies a small but interesting position in bioelectronic medicine. It is a device story that overlaps with healthcare innovation, but it is not a biotech therapeutics name.
Future catalysts
electroCore’s catalysts are gammaCore adoption, migraine and cluster-headache penetration, and any broader neuromodulation update. The market will care about recurring usage and payer support.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of electroCore (ECOR)?
electroCore (ECOR) most recently closed at 6.09 USD, a +0.66% move versus the previous session.
What is the market cap of electroCore (ECOR)?
electroCore currently has a market capitalization of 78.4M USD on BioPharmSignal.
What does electroCore do?
electroCore is a bioelectronic medicine company focused on non-invasive vagus nerve stimulation and related neuromodulation applications. Its business centers on device-based therapy rather than traditional pharmaceuticals.
On which exchange is ECOR stock listed?
electroCore (ECOR) is associated with NASDAQ, United States, Biopharma.
What future catalysts are investors watching for electroCore?
electroCore’s catalysts are gammaCore adoption, migraine and cluster-headache penetration, and any broader neuromodulation update. The market will care about recurring usage and payer support.